CARA THERAPEUTICS INC. - COMMON STOCK
0.3051
22-November-24 15:44:58
15 minutes delayed
Stocks
-0.0049
-1.58%
Today's range
0.2831 - 0.3160
ISIN
N/A
Source
NASDAQ
-
Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023
23 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
25 Sep 2023 06:00:32 By Nasdaq GlobeNewswire
-
Cara Therapeutics Reports Second Quarter 2023 Financial Results
07 Aug 2023 15:01:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors
03 Aug 2023 06:00:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
02 Aug 2023 06:00:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Present at the Jefferies Healthcare Conference
01 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
18 May 2023 01:00:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics Reports First Quarter 2023 Financial Results
15 May 2023 15:01:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023
01 May 2023 06:00:01 By Nasdaq GlobeNewswire
-
Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference
10 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics Releases Inaugural Environmental, Social, and Governance Report
14 Mar 2023 06:00:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results
06 Mar 2023 15:01:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
21 Feb 2023 06:00:02 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Host Capital Markets Day on Thursday, February 16, 2023
17 Jan 2023 06:00:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 06:00:01 By Nasdaq GlobeNewswire
-
Cara Therapeutics Reports Third Quarter 2022 Financial Results
07 Nov 2022 15:01:01 By Nasdaq GlobeNewswire
-
Cara Therapeutics Announces Appointment of Lisa von Moltke, M.D., to its Board of Directors
03 Nov 2022 06:00:01 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Present at Upcoming Investor Conferences
02 Nov 2022 06:00:02 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022
24 Oct 2022 06:00:00 By Nasdaq GlobeNewswire